The Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization established in 1953 to advance the discovery and development of safe and effective immunotherapies for cancer, today announced the relaunch of the open access, online journal Cancer Immunity, the official journal of the Cancer Research Institute. Cancer Immunity, first established in 2001, is the only journal in the field of cancer immunology and immunotherapy dedicated to open acesss, as well as to providing a broad set of resources and opportunities for interaction and exchange that go beyond the traditional scientific journal model to openly and comprehensively facilitate knowledge sharing and accelerate research.
"At this time in cancer immunology and immunotherapy, there is a great need to access and share research results and tools rapidly to move the field forward faster," says James P. Allison, editor-in-chief of Cancer Immunity and director of the CRI Scientific Advisory Council. "Cancer Immunity is the only journal of its kind, committed to providing open access to a great breadth and depth of valuable scientific resources, enabling it to advance the field in a way that cannot be achieved through the traditonal journal model."